Prime analysis
Discerning duplicate drug therapy is not the patient’s job
Patients don't want to understand cross-benefit coordination of therapy. They're trying to get well.
August 31, 2020
Related research
Prime analysis
March 22, 2022
Preparing clients for gene therapy sticker shock
When Prime helps health plan clients get ready for cost increases from a…
Prime analysis
March 17, 2022
Unexpected impacts of COVID-19 go deep in health care, affecting the progress of gene therapy
The impact of COVID-19 on our country has been deep and profound. In…
Prime analysis
February 24, 2022
Strategy for treating osteoporosis at high risk for fracture using MedDrive™
About 10 million Americans have osteoporosis, a disease of the bone that makes…